Related Experiment Video
Updated: May 7, 2026

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
Design and fabrication of a platform for circulating tumor cells (CTCs) isolation and detection by MiRGD@NTA@Au-Fe3O4
Zahra Abdollahi1, Yasaman-Sadat Borghei2, Saman Hosseinkhani3
1Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, P. O. Box: 14115-154, Iran.
Abstract:
To enable simple and rapid detection of circulating tumor cells (CTCs), we developed a targeted colorimetric biosensor based on MiRGD-functionalized Fe3O4-PEI-Au nanoparticles conjugated with TGA and Ni+2-NTA (MiRGD@NTA@Au-Fe3O4 nanoparticles). The biosensor enables magnetic separation of target cells and visual signal generation through the peroxidase-mimicking activity of Au-Fe3O4 nanoparticles, using TMB as a substrate. Colorimetric signals were monitored at 650 nm and discerned by the naked eye. Spectral data and fluorescence microscopy confirmed the specific binding of MiRGD peptides to cancer cells, ensuring discrimination from non-cancerous cells. Under optimized conditions, the assay exhibited a linear response for MDA-MB-231 cells suspended in PBS in the range of 5-5000 cells/mL, with a limit of detection (LOD) 6 cell/mL. The biosensor also demonstrated robust performance in human blood samples, with LOD 8 cell/mL, confirming its applicability in complex biological environments. These results highlight MiRGD@NTA@Au-Fe3O4 nanoparticles as a promising platform for simple, rapid, and high-sensitivity detection of CTCs, offering potential for clinical diagnostics and personalized cancer monitoring.

